Emergent BioSolutions (EBS) Misses Q1 EPS by 1c, Reaffirms Guidance
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $5.11 +0.59%
Financial Fact:
Earnings per share - diluted: 0.45
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Earnings per share - diluted: 0.45
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.29, $0.01 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $116.9 million versus the consensus estimate of $116.17 million.
Emergent BioSolutions reaffirmed guidance.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
- H.B. Fuller board rejects Ancora's $1.1B-$1.2B BAS unit bid
- JPMorgan Reinstates Emergent BioSolutions (EBS) at Underweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
